Hookipa Biotech Gmbh

Vera Baumgartl-Strasser

Thomas P Monath

Katherine Cohen

Farshad Guirakhoo

Karen Lingnau

Klaus Orlinger

Andreas Aspöck

Gerhard Fuhrmann

Elizabeth Watson

Bettina Kiefmann

Manuela Kainer

Bernhard Brim

Mario Aistleithner

Katharina Bayer

Elsa Mühlbacher

Elsa Muhlbacher

Thomas Monath

Andreas ASPÖCK

Elsa MÜHLBACHER

Andreas Aspock

Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of cytomegalovirus infections and reactivation. Also provided herein are pharmaceutical compositions and methods for the treatment of cytomegalovirus infections and reactivation. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating cytomegalovirus infections and reactivation.

CMV vaccines

The present application provides immunotherapies for Hepatitis B virus infections. Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of Hepatitis B virus infections. Also provided herein are pharmaceutical compositions and methods for the treatment of Hepatitis B virus infections. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating Hepatitis B virus infection.

Vaccines against hepatitis B virus

Growing community of inventors

Purkersdorf, Austria

Vera Baumgartl-Strasser